KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Interest Coverage Ratio (2020 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Interest Coverage Ratio for 7 consecutive years, with 3.88 as the latest value for Q1 2026.

  • For Q1 2026, Interest Coverage Ratio rose 1150.63% year-over-year to 3.88; the TTM value through Mar 2026 reached 3.43, up 590.18%, while the annual FY2025 figure was 1.99, 259.23% up from the prior year.
  • Interest Coverage Ratio hit 3.88 in Q1 2026 for Alnylam Pharmaceuticals, up from 2.01 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 8.29 in Q3 2025 and bottomed at 7.65 in Q2 2023.
  • Average Interest Coverage Ratio over 5 years is 1.22, with a median of 2.24 recorded in 2024.
  • Year-over-year, Interest Coverage Ratio plummeted 132.32% in 2024 and then soared 1150.63% in 2026.
  • Alnylam Pharmaceuticals' Interest Coverage Ratio stood at 6.31 in 2022, then surged by 41.09% to 3.71 in 2023, then rose by 27.35% to 2.7 in 2024, then surged by 174.64% to 2.01 in 2025, then soared by 92.51% to 3.88 in 2026.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 3.88, 2.01, and 8.29 for Q1 2026, Q4 2025, and Q3 2025 respectively.